Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Vyome Holdings, Inc.

News headline image
Livechain Completes Acquisition of Senior, Secured Debt of Humanyze, An MIT Incubated, AI Enabled HR Analytics Company
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Independent Analyst Values Vyome’s VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Holdings Announces Results of Annual Shareholder Meeting
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Holdings Acquires MIT AI Spinout Oculo Health
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
News headline image
Vyome Announces Strategic Review of Livechain (OTCID: LICH)
From Vyome Holdings, Inc.
Via Business Wire
Tickers HIND
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.